Literature DB >> 11531944

Flow cytometric measurement of intracellular migration inhibition factor and tumour necrosis factor alpha in the mucosa of patients with coeliac disease.

J O'Keeffe1, S Lynch, A Whelan, J Jackson, N P Kennedy, D G Weir, C Feighery.   

Abstract

There is increasing evidence that proinflammatory cytokines contribute to many of the small intestinal features in coeliac disease. The aim of the study was to investigate the expression of two proinflammatory cytokines, migration inhibition factor (MIF) and tumour necrosis factor alpha (TNF-alpha) in duodenal biopsy specimens from patients with coeliac disease on a gluten-free diet and normal control subjects. A flow cytometric system was used to analyse intracellular protein levels of MIF and TNF-alpha in freshly isolated cells from duodenal biopsies taken from 12 patients with treated coeliac disease and 10 healthy control subjects. From the biopsy specimens, single cell suspensions of the epithelium and lamina propria were prepared using EDTA/DTT and enzymes. Intracellular cytokine expression was studied in intraepithelial lymphocytes (IELs), lamina propria T cells (LP T) and intestinal epithelial cells using different surface labelling antibodies. MIF protein was constitutively expressed in IELs, LP T cells and epithelial cells from normal intestinal mucosa. In contrast, although TNF-alpha was found in LP T cells, this cytokine was virtually undetectable in either IELs or epithelial cells. In coeliac disease, intracellular levels of MIF were significantly higher in epithelial cells compared with control subjects (P = 0.005). Raised levels of TNF-alpha were found in epithelial cells (P = 0.03) as well as IELs (P = 0.045) from coeliac patients compared with controls. The findings from this study show up-regulated expression of MIF and TNF-alpha in IELs and epithelial cells of histologically normal mucosa in patients with coeliac disease. Increased expression of proinflammatory cytokines in cells occupying the epithelial layer could help explain the rapidity with which the coeliac mucosa may respond to gluten challenge.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11531944      PMCID: PMC1906145          DOI: 10.1046/j.1365-2249.2001.01594.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  32 in total

1.  In vivo antigen challenge in celiac disease identifies a single transglutaminase-modified peptide as the dominant A-gliadin T-cell epitope.

Authors:  R P Anderson; P Degano; A J Godkin; D P Jewell; A V Hill
Journal:  Nat Med       Date:  2000-03       Impact factor: 53.440

Review 2.  The pathophysiology of tumor necrosis factors.

Authors:  P Vassalli
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

3.  Recombinant migration inhibitory factor induces nitric oxide synthase in murine macrophages.

Authors:  F Q Cunha; W Y Weiser; J R David; D W Moss; S Moncada; F Y Liew
Journal:  J Immunol       Date:  1993-03-01       Impact factor: 5.422

4.  Epithelial cells secrete the chemokine interleukin-8 in response to bacterial entry.

Authors:  L Eckmann; M F Kagnoff; J Fierer
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

5.  Mechanism of a reaction in vitro associated with delayed-type hypersensitivity.

Authors:  B R Bloom; B Bennett
Journal:  Science       Date:  1966-07-01       Impact factor: 47.728

6.  Numbers of T cell receptor (TCR) alpha beta+ but not of TcR gamma delta+ intraepithelial lymphocytes correlate with the grade of villous atrophy in coeliac patients on a long term normal diet.

Authors:  T Kutlu; N Brousse; C Rambaud; F Le Deist; J Schmitz; N Cerf-Bensussan
Journal:  Gut       Date:  1993-02       Impact factor: 23.059

7.  MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia.

Authors:  J Bernhagen; T Calandra; R A Mitchell; S B Martin; K J Tracey; W Voelter; K R Manogue; A Cerami; R Bucala
Journal:  Nature       Date:  1993-10-21       Impact factor: 49.962

8.  Interleukin-6 and its receptor are expressed in human intestinal epithelial cells.

Authors:  K Shirota; L LeDuy; S Y Yuan; S Jothy
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1990

9.  Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function.

Authors:  R A Daynes; B A Araneo; T A Dowell; K Huang; D Dudley
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

10.  Gliadin-specific, HLA-DQ(alpha 1*0501,beta 1*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients.

Authors:  K E Lundin; H Scott; T Hansen; G Paulsen; T S Halstensen; O Fausa; E Thorsby; L M Sollid
Journal:  J Exp Med       Date:  1993-07-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Tests for Serum Transglutaminase and Endomysial Antibodies Do Not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.

Authors:  Jocelyn A Silvester; Satya Kurada; Andrea Szwajcer; Ciarán P Kelly; Daniel A Leffler; Donald R Duerksen
Journal:  Gastroenterology       Date:  2017-05-22       Impact factor: 22.682

2.  Spontaneous mucosal lymphocyte cytokine profiles in children with autism and gastrointestinal symptoms: mucosal immune activation and reduced counter regulatory interleukin-10.

Authors:  Paul Ashwood; Andrew Anthony; Franco Torrente; Andrew J Wakefield
Journal:  J Clin Immunol       Date:  2004-11       Impact factor: 8.317

3.  Altered gene expression in highly purified enterocytes from patients with active coeliac disease.

Authors:  Suzanne Bracken; Greg Byrne; Jacinta Kelly; John Jackson; Conleth Feighery
Journal:  BMC Genomics       Date:  2008-08-08       Impact factor: 3.969

4.  TNF-α -308 G > A (rs1800629) Polymorphism is Associated with Celiac Disease: A Meta-analysis of 11 Case-Control Studies.

Authors:  Saif Khan; Raju K Mandal; Arshad Jawed; Sajad A Dar; Mohd Wahid; Aditya K Panda; Mohammed Y Areeshi; Md Ekhlaque Ahmed Khan; Shafiul Haque
Journal:  Sci Rep       Date:  2016-09-06       Impact factor: 4.379

5.  Younger age at diagnosis predisposes to mucosal recovery in celiac disease on a gluten-free diet: A meta-analysis.

Authors:  Zsolt Szakács; Péter Mátrai; Péter Hegyi; Imre Szabó; Áron Vincze; Márta Balaskó; Bernadett Mosdósi; Patrícia Sarlós; Mária Simon; Katalin Márta; Alexandra Mikó; Dániel Pécsi; Alexandra Demcsák; Judit Bajor
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

Review 6.  The Role of Monocytes and Macrophages in Autoimmune Diseases: A Comprehensive Review.

Authors:  Wen-Tao Ma; Fei Gao; Kui Gu; De-Kun Chen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

7.  Suppression of Transmembrane Tumor Necrosis Factor Alpha Processing by a Specific Antibody Protects Against Colitis-Associated Cancer.

Authors:  Hongping Ba; Rui Jiang; Meng Zhang; Bingjiao Yin; Jing Wang; Zhuoya Li; Baihua Li; Xiaoxi Zhou
Journal:  Front Immunol       Date:  2021-10-05       Impact factor: 7.561

8.  Cell-mediated reduction of human β-defensin 1: a major role for mucosal thioredoxin.

Authors:  S U Jaeger; B O Schroeder; U Meyer-Hoffert; L Courth; S N Fehr; M Gersemann; E F Stange; J Wehkamp
Journal:  Mucosal Immunol       Date:  2013-04-10       Impact factor: 7.313

Review 9.  Coeliac Disease Pathogenesis: The Uncertainties of a Well-Known Immune Mediated Disorder.

Authors:  Margaret R Dunne; Greg Byrne; Fernando G Chirdo; Conleth Feighery
Journal:  Front Immunol       Date:  2020-07-08       Impact factor: 7.561

10.  Oncogenetic landscape of lymphomagenesis in coeliac disease.

Authors:  Ludovic Lhermitte; Georgia Malamut; Sofia Berrabah; Sascha Cording; Amélie Trinquand; Nicolas Guegan; Patrick Villarese; Sophie Kaltenbach; Bertrand Meresse; Sherine Khater; Michael Dussiot; Marc Bras; Morgane Cheminant; Bruno Tesson; Christine Bole-Feysot; Julie Bruneau; Thierry Jo Molina; David Sibon; Elizabeth Macintyre; Olivier Hermine; Christophe Cellier; Vahid Asnafi; Nadine Cerf-Bensussan
Journal:  Gut       Date:  2021-02-12       Impact factor: 23.059

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.